Bibliography
Export 31 results:
Filters: Keyword is risk [Clear All Filters]
Safety of assisted reproductive technology in the United States, 2000-2011. JAMA//JAMA. 2015;313(1):88-90.
ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues. Human reproduction (Oxford, England)//Hum Reprod. 2014;29(7):1353-9.
Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants. Cancer medicine// Cancer Med. 2014;3(5):1440-7.
Solid organ transplant donors with central nervous system infection. Transplantation// Transplantation. 2014;98(6):666-70.
Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion// Transfusion. 2012;52(4):880-92.
What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation?. Transplantation proceedings//Transplant Proc. 2011;43(9):3516-20.
Heritable disease and sperm donation. JAMA. 2010;303(7):617-8; - author - reply - 618-9.
How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data. Am J Transplant. 2010;10(6):1437-44.
Occult donor metastatic adenocarcinoma. Contribution of the forensic autopsy. A case report. Ann Transplant. 2010;15(1):67-71.
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009;15(10):5.
Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;14(9 Suppl):29-36.
Transmission of Human Immunodeficiency Virus and Hepatitis C Virus Through Liver Transplantation. Liver Transplant. 2008;14(11):1603-1608.
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2005;90(7):969-75.
[Latex-induced anaphylactic shock following graft reperfusion during renal transplantation]. Ann Fr Anesth Reanim. 2005;24(5):547-50.
Transplantation of a liver graft from a living donor with early gastric cancer. Am J Transplant. 2005;5(9):2331-2; - author - reply - 2333.
Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med. 2004;350(25):2564-71.
Organ donors with malignant gliomas: an update. Am J Transplant. 2004;4(1):15-21.
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion//Transfusion. 2004;44(9):1273-81.
Critical overview of the current status of organ donors with primary central nervous system tumors. Ann Transplant. 2002;7(1):6-14.
Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation. 2002;74(10):1409-13.
Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995. Acta Orthop Scand. 1998;69(6):559-65.
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334(26):1685-90.
Low risk of liver disease after tissue transplantation from donors with HCV. Lancet. 1993;341(8849):903-904.
Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression. J Am Soc Nephrol. 1992;2(12 Suppl):S290-4.